PEDRO TOMAS RAMIREZ to Camptothecin
This is a "connection" page, showing publications PEDRO TOMAS RAMIREZ has written about Camptothecin.
Connection Strength
0.063
-
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Int J Gynecol Cancer. 2008 May-Jun; 18(3):460-4.
Score: 0.063